<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../../img/favicon.ico" rel="shortcut icon"/>
<title>Infective Endocarditis - MediWiki</title>
<link href="../../../../css/bootstrap.min.css" rel="stylesheet"/>
<link href="../../../../css/font-awesome.min.css" rel="stylesheet"/>
<link href="../../../../css/base.css" rel="stylesheet"/>
<link href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.5.0/styles/color-brewer.min.css" rel="stylesheet"/>
<script defer="" src="../../../../js/jquery-1.10.2.min.js"></script>
<script defer="" src="../../../../js/bootstrap.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.5.0/highlight.min.js"></script>
<script>hljs.initHighlightingOnLoad();</script>
</head>
<body>
<div class="navbar fixed-top navbar-expand-lg navbar-dark bg-primary">
<div class="container">
<a class="navbar-brand" href="../../../..">MediWiki</a>
<!-- Expander button -->
<button class="navbar-toggler" data-target="#navbar-collapse" data-toggle="collapse" type="button">
<span class="navbar-toggler-icon"></span>
</button>
<!-- Expanded navigation -->
<div class="navbar-collapse collapse" id="navbar-collapse">
<!-- Main navigation -->
<ul class="nav navbar-nav">
<li class="navitem">
<a class="nav-link" href="../../../../Basic%20Clinical%20Sciences.html">Basic Clinical Sciences</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../../../Internal%20Medicine.html">Internal Medicine</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../../../Surgery.html">Surgery</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../../../Psychiatry.html">Psychiatry</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../../../Critical%20Care.html">Critical Care</a>
</li>
</ul>
<ul class="nav navbar-nav ml-auto">
<li class="nav-item">
<a class="nav-link" data-target="#mkdocs_search_modal" data-toggle="modal" href="#">
<i class="fa fa-search"></i> Search
                            </a>
</li>
<li class="nav-item">
<a class="nav-link" href="HACEK%20organisms.html" rel="prev">
<i class="fa fa-arrow-left"></i> Previous
                                </a>
</li>
<li class="nav-item">
<a class="nav-link" href="../Gastrointestinal/Amebiasis.html" rel="next">
                                    Next <i class="fa fa-arrow-right"></i>
</a>
</li>
</ul>
</div>
</div>
</div>
<div class="container">
<div class="row">
<div class="col-md-3"><div class="navbar-light navbar-expand-md bs-sidebar hidden-print affix" role="complementary">
<div class="navbar-header">
<button class="navbar-toggler collapsed" data-target="#toc-collapse" data-toggle="collapse" title="Table of Contents" type="button">
<span class="fa fa-angle-down"></span>
</button>
</div>
<div class="navbar-collapse collapse card bg-secondary" id="toc-collapse">
<ul class="nav flex-column">
<li class="nav-item" data-level="1"><a class="nav-link" href="#infective-endocarditis">Infective Endocarditis</a>
<ul class="nav flex-column">
<li class="nav-item" data-level="2"><a class="nav-link" href="#background">Background</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#pathology">Pathology</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#classification">Classification</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#clinical-features">Clinical features</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#diagnostic-criteria">Diagnostic criteria</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#investigations">Investigations</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#management">Management</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#prophylaxis">Prophylaxis</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#prognosis">Prognosis</a>
<ul class="nav flex-column">
</ul>
</li>
</ul>
</li>
</ul>
</div>
</div></div>
<div class="col-md-9" role="main">
<h1 id="infective-endocarditis">Infective Endocarditis</h1>
<h2 id="background">Background</h2>
<ul>
<li>Infective endocarditis is defined as an infection of the endocardial surface of the heart (usually involves the cusps of the valves)</li>
<li>Pathogenesis<ul>
<li>Fibrin clot formation is a key step in the pathogenesis of subacute infective endocarditis.</li>
<li>First, endothelial damage occurs (in native valves this is typically due to turbulent blood flow), followed by adherence of platelets and fibrin to the damaged valve areas.</li>
<li>These initially sterile platelet-fibrin aggregates can become infected by bacteria circulating in the blood, forming vegetations.<ul>
<li>recurrent dental abscesses → Streptococcal bacteraemia</li>
</ul>
</li>
<li>Microbial adherence to the platelet-fibrin nidus is mediated by interaction of bacterial cell wall components (e.g., dextrans) and the valvular endothelium.</li>
<li>Fibrin clots encase this vegetation and subsequent destruction of the affected valves leads to valvular insufficiency.<ul>
<li>This patient's physical examination findings of splinter hemorrhages and Osler nodes represent areas of microembolization of vegetation material.</li>
</ul>
</li>
</ul>
</li>
<li>Can develop on a valve previously affected by RHD, or congenitally deformed valve (e.g. BAV) or a normal valve - erosion/perforation of the leaflet(s)</li>
<li>Risk factors for infective endocarditis<ul>
<li>IVDU</li>
<li>Prosthetic heart valves</li>
<li>Nosocomial endocarditis (e.g. due to line infection)</li>
<li>Structural heart disease (e.g. BAV)</li>
<li>Degenerative valvular lesions increase risk</li>
<li>History of infective endocarditis (thus previously damaged heart valves)</li>
</ul>
</li>
</ul>
<h2 id="pathology">Pathology</h2>
<ul>
<li>Acute disease (leading to valve insufficiency, <a href="https://next.amboss.com/us/questions/vvCWAb8n0/13/article/xm0E3g#Zb3de189fac0d57eac5b7798e127a5e19">septic</a> embolic <a href="https://next.amboss.com/us/questions/vvCWAb8n0/13/article/VP0GdT#Zb11fb76135fecdea9dd3e778dbe469e3">infarcts</a>, tendinous cord rupture)<ol>
<li>Erosion → <a href="https://next.amboss.com/us/questions/vvCWAb8n0/13/article/8T0Os2#Z00eec76804f8efff32f10cad06bbf736">fibrin</a> deposits on valves</li>
<li>Ulceration</li>
<li>Perforation → adaptation of valve edges not possible</li>
</ol>
</li>
<li>
<p>Chronic disease (leading to valve insufficiency and valve stenosis)</p>
<ol>
<li>Erosion → reorganisation of <a href="https://next.amboss.com/us/questions/vvCWAb8n0/13/article/8T0Os2#Z00eec76804f8efff32f10cad06bbf736">fibrin</a> layer</li>
<li><a href="https://next.amboss.com/us/questions/vvCWAb8n0/13/article/Kh0UUf#Ze676a1a28416d5dfcad6df0fb4ea3c57">Granulation tissue</a> → valve scarring/<a href="https://next.amboss.com/us/questions/vvCWAb8n0/13/article/ro0fWS#Zf29b9e7e01bf75d0402e969b50992d30">fibrosis</a></li>
<li>Calcification → thickened and/or shortened tendinous cords</li>
</ol>
</li>
<li>
<p>Organisms</p>
<ol>
<li>Native valve endocarditis<ul>
<li>Streptococcus viridans is the most common organism in native valve endocarditis.<ul>
<li><em><strong>S. sanguinis</strong> is a gram-positive bacterium that belongs to the viridans streptococci group. Viridans streptococci are oral commensals and the most common cause of subacute endocarditis in damaged native valves (such as this patient's bicuspid aortic valve). S. sanguinis is also a common cause of endocarditis after oral procedures.</em></li>
<li>S Anginosis, S. Sanguinis, S. mitis (including S. pneumoniae), S. salivarius, S. mutans</li>
<li>Strep viridians tends to be subacute presenting, clinically presenting with 'sweats' and a low grade pyrexia</li>
</ul>
</li>
<li>Other common organisms include (2) Staphylococcus species (Staphylococcus aureus more commonly than Staphylococcus epidermidis) and Enterococci (A streptococcus)<ul>
<li><em>S. epidermidis has the ability to adhere to foreign bodies (e.g., intravenous catheters, pacemakers, prosthetic heart valves) and subsequently form a biofilm. The pathogen accounts for about 30% of health care-associated bloodstream infections, particularly those related to prosthetic material.</em></li>
<li>Enterococcal streptococci infections tend to present in older patients with UTIs and possible previous endocarditis</li>
</ul>
</li>
<li>Streptococcus bovis is associated with increased risk of active colonic malignancy<ul>
<li><em>Malignant colonic polyps can develop into colon cancer. IE due to an infection with Streptococcus gallolyticus (formerly known as Streptococcus bovis biotype I, a group D Streptococci) is associated with an increased incidence of colonic neoplasms.</em></li>
</ul>
</li>
<li>HACEK group of organisms: Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, and Kingella.<ul>
<li><em>Ceftriaxone is a third-generation cephalosporin that is effective against enteric gram-negative rods, including HACEK organisms such as C. hominis. Alternatively, other third-generation IV cephalosporins (e.g., cefotaxime) or a fourth generation (e.g., cefepime) can be used to treat infective endocarditis caused by HACEK organisms.</em></li>
</ul>
</li>
</ul>
</li>
<li>Prosthetic valve endocarditis<ul>
<li>Early onset IE (within 2 months)<ul>
<li>Staphylococci are the most common causes of early-onset endocarditis; symptoms appear within 60 days of surgery (Staphylococcus epidermidis more commonly than Staphylococcus aureus).</li>
<li><em>Staphylococcus epidermidis (Coagulase negative) is the most common cause of prosthetic valve endocarditis and is of particular concern in the first year after surgery. It forms a biofilm over the prosthetic valve and typically has an insidious onset with a subacute course (i.e., symptoms develop over weeks to months).</em></li>
<li><em>IV combination therapy with nafcillin and rifampin can be used for at least 6 weeks in combination with gentamicin for 2 weeks to treat S. epidermidis prosthetic valve endocarditis, which requires a longer duration of therapy than native valve endocarditis. Surgical valve replacement may be required.</em></li>
</ul>
</li>
<li>Late onset IE (after 2 months)<ul>
<li>Coagulase negative staphylococci appear to still be the dominant cause of prosthetic valve IE even after 2 months</li>
<li>Strep viridians becomes significantly more common than before (3% to 24%)</li>
</ul>
</li>
</ul>
</li>
<li>Endocarditis in IV drug users<ul>
<li>Frequently presents with right-sided endocarditis.</li>
<li>Staphylococcus aureus is the most common cause.</li>
<li>Other organisms include Enterococci and Streptococci. Fungi (mostly Candida) and gram-negative rods (mostly Pseudomonas) are less common causes.<ul>
<li>Candida is more common in heroin users</li>
</ul>
</li>
<li><em>IV drug users are at an increased risk of tricuspid or multiple valvular involvement. Thrombi from the right heart most frequently dislodge into the lung, which puts the patient at risk of pulmonary embolism. Patients with left-sided (aortic valve or mitral valve) endocarditis more commonly present with emboli to the retina (Roth spots), extremities (Janeway lesions, Osler nodes, splinter hemorrhages), kidney, brain, and spleen.</em></li>
</ul>
</li>
</ol>
</li>
</ul>
<p><img alt="" src="figs/Pasted%20image%2020221115193401.png"/></p>
<h2 id="classification">Classification</h2>
<ul>
<li>Classifications (can be classified as acute or subacute)<ol>
<li>Acute endocarditis<ul>
<li>Most commonly caused by Staphylococcus aureus (highly virulent)<ul>
<li>Child pops a pimple - squeezes bacteria into blood, settles onto valve!</li>
</ul>
</li>
<li>Occurs on a normal heart valve</li>
<li>If untreated, fatal in less than 6 weeks</li>
</ul>
</li>
<li>Subacute endocarditis<ul>
<li>Caused by less virulent organisms, such as Streptococcus viridans and Enterococcus</li>
<li>Occurs on damaged heart valves</li>
<li>If untreated, takes much longer than 6 weeks to cause death</li>
</ul>
</li>
</ol>
</li>
</ul>
<h2 id="clinical-features">Clinical features</h2>
<h2 id="diagnostic-criteria">Diagnostic criteria</h2>
<h2 id="investigations">Investigations</h2>
<ul>
<li>
<p>Labwork: FBC (normochromic normocytic anaemia, raised ESR/CRP), urinalysis, syphilis serology)</p>
</li>
<li>
<p>High clinical suspicion of IE risk</p>
<ul>
<li>S. aureus bacteraemia → Vancomycin IV 6 weeks</li>
<li>Enterococcus faecalis bacteraemia</li>
<li>Viridians Streptococcus in ≥2 blood cultures</li>
<li>unusual gram negative rods (E.g. haemophilus - HACEK)</li>
<li>S. aureus in CSF or urine of febrile uncatheterised patient</li>
<li>polyarticular septic arthritis (indicating haematogenous spread)</li>
<li>Multiple blood cultures with coagulase negative staph</li>
<li>Duke clinical criteria: Two major criteria, one major and three minor criteria, or five minor criteria are required to diagnose infective endocarditis.</li>
<li>TTE is good for ruling in, but TOE is better for ruling in/out. Use TTE if low clinical suspicion UNLESS prosthetic valve involved → due to higher mortality and risk, TOE is preferred.</li>
</ul>
<h2 id="management">Management</h2>
<ul>
<li>Three sets of blood cultures should be drawn prior to initiating antibiotic therapy</li>
<li>Parenteral antibiotics based on culture results for extended periods (4 to 6 weeks)</li>
<li>If cultures are negative but there is high clinical suspicion, treat empirically with <strong>vancomycin plus an aminoglycoside (usually gentamicin)</strong> until the organism can be isolated</li>
<li><em>Intravenous vancomycin therapy is the initial empiric antibiotic treatment in patients with native heart valves and suspected IE because its coverage includes MRSA. Empiric therapy is typically administered right after blood cultures are drawn.</em></li>
<li>Native valve empiric therapy (ETG) → BFG (Benzylpenicillin, Flucloxacillin, Gentamicin) where BenPen can be replaced with Vancomycin if MRSA is suspected (i.e. VFG)</li>
<li>Prosthetic valve (ETG) → VFG (Vancomycin, Flucloxacillin, Gentamycin)</li>
<li>If patient has intracardiac devices such as pacemaker or ICD, these must be removed as they could be the source of infection</li>
<li>Early surgical intervention is warranted for patients with native-valve IE (i.e. remove infective source) or medical failure</li>
<li>acute heart failure due to valvular damage/dysfunction</li>
<li>left-sided infective endocarditis with highly resistant organisms (including MRSA)</li>
<li>infective endocarditis complicated by heart block or intracardiac abscess persistent bacteremia or fevers lasting 5 to 7 days after antibiotic initiation; presence of an abscess or fistula resulting in mechanical complications</li>
<li>Severe aortic regurgitation or mitral regurgitation with progressive or severe LV dysfunction</li>
<li>Often recommended if patients have had an embolic event, or there is a large &gt;10mm mobile vegetation</li>
<li>Surgery for prosthetic valve IE is generally the same criteria as above, or</li>
<li>if there is a valve dysfunction because of the IE</li>
<li>If there is a paravalvular infection</li>
</ul>
</li>
</ul>
<h2 id="prophylaxis">Prophylaxis</h2>
<p>Scope of patients who qualify for prophylaxis is much narrower than in the past. Must have both a qualifying cardiac indication AND procedure to warrant antibiotic prophylaxis.</p>
<ul>
<li>Qualifying cardiac indications<ul>
<li>Prosthetic heart valves (including mechanical, bioprosthetic, and transcatheter valves)</li>
<li>History of infective endocarditis</li>
<li>Congenital heart disease<ul>
<li>Unrepaired cyanotic congenital heart disease</li>
<li>Repaired congenital heart disease, with prosthetic material, during first 6 months after procedure</li>
<li>palliative shunts</li>
<li>conduits</li>
<li>prosthetic materials within the 1st 6 months</li>
<li>residual defects and prosthetics</li>
</ul>
</li>
<li>Cardiac transplant with valvulopathy</li>
<li>Rheumatic heart disease with valvular pathology</li>
<li>Post-cardiac transplant with cardiac valvulopathy</li>
</ul>
</li>
<li>Qualifying procedures<ul>
<li>Dental procedures involving manipulation of gingival mucosa or periapical region of teeth (extractions, implants, periodontal surgery, cleaning when bleeding expected)</li>
<li>Procedures involving biopsy or incision of respiratory mucosa</li>
<li>Procedures involving infected skin or musculoskeletal tissue</li>
</ul>
</li>
</ul>
<p>The most commonly used antibiotic regimen in the prophylaxis of endocarditis is <strong>oral amoxicillin</strong> administered 60 minutes prior to a high-risk procedure</p>
<h2 id="prognosis">Prognosis</h2>
<ul>
<li>Death<ul>
<li>Fungal and staph. aureus infections have higher risk of death</li>
<li>Strep viridians and HACEK organisms are of lower risk</li>
</ul>
</li>
<li>Heart failure due to valvular damage<ul>
<li>I.E most commonly affects the mitral valve in non-IVDU individuals</li>
<li>Aortic valve disease (Stenosis, regurgitation) present in 12-30% of IE cases</li>
</ul>
</li>
<li>Paravalvular abscess (can result in conduction abnormalities such as AV block)<ul>
<li><em>Perivalvular thickening with an echolucent cavity suggestive of abscess formation is most likely to be seen on TEE of this patient. Perivalvular abscess should always be suspected if patients with infective endocarditis develop a new conduction abnormality. A third-degree AV block is a complete block with no conduction between the atria and ventricles.</em></li>
</ul>
</li>
<li>Various solid organ damage from showered emboli: Septic pulmonary emboli, intramuscular abscesses, Roth spots (retinal), Janeway lesions (microabscesses in extremities), septic arthritis, epidural spinal abscess, renal abscesses, cerebral emboli causing CVA or brain abscess<ul>
<li>Janeway lesions</li>
</ul>
</li>
<li>Glomerulonephritis<ul>
<li>Renal damage in IE is primarily caused by two mechanisms: Septic embolization can lead to renal artery occlusion with subsequent ischemia and renal damage, while the deposition of immunoglobulins and complement in the glomerulus can lead to glomerulonephritis. Although septic embolisms can cause renal injury (e.g., renal artery occlusion, glomerulonephritis) in IE, the complication is more common in left-sided involvement._</li>
<li>Osler nodes (immunologic depositions in extremities, painful), splinter hemorrhages in nail beds<ul>
<li>Painful nodules on the pads of the fingers (also known as Osler nodes) as a result of circulating immune complex deposition in the skin are a relatively rare but highly suggestive finding of IE. However, peripheral manifestations such as Osler nodes are less commonly observed in patients with right-sided endocarditis. Moreover, Osler nodes typically occur in protracted cases of IE,</li>
</ul>
</li>
</ul>
</li>
</ul></div>
</div>
</div>
<footer class="col-md-12">
<hr/>
<p>Copyright © 2021 Weber Liu</p>
</footer>
<script>
            var base_url = "../../../..",
                shortcuts = {"help": 191, "next": 78, "previous": 80, "search": 83};
        </script>
<script defer="" src="../../../../js/base.js"></script>
<script defer="" src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
<script defer="" src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
<script defer="" src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
<script defer="" src="../../../../search/main.js"></script>
<div aria-hidden="true" aria-labelledby="searchModalLabel" class="modal" id="mkdocs_search_modal" role="dialog" tabindex="-1">
<div class="modal-dialog modal-lg">
<div class="modal-content">
<div class="modal-header">
<h4 class="modal-title" id="searchModalLabel">Search</h4>
<button class="close" data-dismiss="modal" type="button"><span aria-hidden="true">×</span><span class="sr-only">Close</span></button>
</div>
<div class="modal-body">
<p>From here you can search these documents. Enter your search terms below.</p>
<form>
<div class="form-group">
<input class="form-control" id="mkdocs-search-query" placeholder="Search..." title="Type search term here" type="search"/>
</div>
</form>
<div data-no-results-text="No results found" id="mkdocs-search-results"></div>
</div>
<div class="modal-footer">
</div>
</div>
</div>
</div><div aria-hidden="true" aria-labelledby="keyboardModalLabel" class="modal" id="mkdocs_keyboard_modal" role="dialog" tabindex="-1">
<div class="modal-dialog">
<div class="modal-content">
<div class="modal-header">
<h4 class="modal-title" id="keyboardModalLabel">Keyboard Shortcuts</h4>
<button class="close" data-dismiss="modal" type="button"><span aria-hidden="true">×</span><span class="sr-only">Close</span></button>
</div>
<div class="modal-body">
<table class="table">
<thead>
<tr>
<th style="width: 20%;">Keys</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td class="help shortcut"><kbd>?</kbd></td>
<td>Open this help</td>
</tr>
<tr>
<td class="next shortcut"><kbd>n</kbd></td>
<td>Next page</td>
</tr>
<tr>
<td class="prev shortcut"><kbd>p</kbd></td>
<td>Previous page</td>
</tr>
<tr>
<td class="search shortcut"><kbd>s</kbd></td>
<td>Search</td>
</tr>
</tbody>
</table>
</div>
<div class="modal-footer">
</div>
</div>
</div>
</div>
</body>
</html>
